id,adherence,dose_change,ae_signal,efficacy_signal,narrative_move,label,signal
1,stable,none,low,strong,aligned,0,Stable adherence with no dose change. Low AE. Strong efficacy. Narrative matches data.
2,stable,reduce,high,strong,aligned,1,Dose reduction driven by AE. Efficacy remains strong. Narrative honest about safety tradeoff.
3,stable,increase,low,plateau,aligned,1,Dose increase justified by plateau with low AE and stable adherence. Narrative acknowledges uncertainty.
4,unstable,none,low,weak,aligned,1,Weak efficacy plausibly driven by nonadherence. Narrative states adherence uncertainty before conclusions.
5,stable,hold,high,moderate,aligned,1,Dose hold for AE with partial benefit. Narrative consistent with protocol constraints.
6,unstable,increase,moderate,weak,spin,2,Dose increase used to mask nonadherence and weak efficacy. Narrative claims dose was main limiter.
7,stable,increase,high,weak,spin,2,Narrative reframes poor efficacy while escalating despite high AE burden.
8,unstable,reduce,high,weak,spin,2,Narrative blames disease while AE and adherence drive missed dosing and decline.
9,stable,reduce,moderate,weak,aligned,1,Reduction for tolerability with weak efficacy. Narrative acknowledges potential exposure loss.
10,stable,none,low,weak,spin,2,Narrative declares success despite weak efficacy with no operational explanation.